From With $379M Deal For Ocata, Astellas Buys Stem Cells For Eye Diseases:

Tired Hazel Eye by Michael Gil

Tired Hazel Eye by Michael Gil—

“Tired Hazel Eye” by Michael Gil, via a Creative Commons license https://www.flickr.com/photos/msvg/
https://creativecommons.org/licenses/by/2.0/

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX

Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.

From Our Advertisers

Investment in Wisconsin startups reaches new record total
Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy